Allergies News and Research

Latest Allergies News and Research

Penn investigators discover source of immune molecule involved in nasal polyps, asthma

A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies.

23 May 2018

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

21 May 2018

Ozone exposure at birth linked to increased risk of developing asthma in childhood

A long-term study of the health of Canadian children has found that exposure to ozone (O3), a common air pollutant, at birth was associated with an 82 percent increased risk of developing asthma by age three.

21 May 2018

Clinical trial begins enrollment to test safety of experimental MERS treatments

Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).

18 May 2018

Microglia may play key role in slowing progression of prion diseases, research suggests

Prion diseases are slow degenerative brain diseases that occur in people and various other mammals. No vaccines or treatments are available, and these diseases are almost always fatal. Scientists have found little evidence of a protective immune response to prion infections.

17 May 2018

Researchers explore different strategies to keep kids with asthma out of hospital

Pediatric asthma takes a heavy toll on patients and families alike. Affecting more than 7 million children in the U.S., it's the most common nonsurgical diagnosis for pediatric hospital admission, with costs of more than $570 million annually.

16 May 2018

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

The most severe allergic reaction, anaphylaxis, is the result of an inappropriate immune reaction following the introduction of a usually harmless antigen into the body.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

New test developed for accurate and safe diagnosis of peanut allergies

Researchers from the School of Immunology & Microbial Sciences and the Medical Research Council have developed a new test to diagnose peanut allergy.

14 May 2018

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Knopp Biosciences LLC today announced the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereosinophilic syndromes met its co-primary endpoints.

10 May 2018

Poison ivy and poison oak can cause mild to severe allergic reactions

April showers might bring May flowers, but they also bring the arrival of troublesome plants such as poison ivy and poison oak that can cause mild to severe allergic reactions.

9 May 2018

Mutations in EBOV-Makona do not alter disease-causing ability in animal models, shows study

Early during the recent Ebola epidemic in West Africa, scientists speculated that the genetic diversity of the circulating Makona strain of virus (EBOV-Makona) would result in more severe disease and more transmissibility than prior strains.

9 May 2018

OU researchers receive $5.7 million NIH grant to accelerate antibiotic discovery

University of Oklahoma professors, Helen Zgurskaya and Valentin Rybenkov, and team are addressing the challenge and critical need for new antibiotics that can fight infections caused by the multi-drug resistant bacterium, Pseudomonas aeruginosa, considered an urgent threat by the Centers for Disease Control and Prevention.

7 May 2018

Seasonal allergy symptoms can be misunderstood for learning disabilities in young children

Seasonal allergies can be a nuisance for children as well as adults. And in some young children, the symptoms of seasonal allergies can be mistaken for inattentiveness or learning disabilities.

7 May 2018

Phase 2 clinical study of universal influenza vaccine begins in the United States

A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.

4 May 2018

New eye drop may be potentially effective in treating seasonal eye allergies

A recent study shows that a new eye drop may be a potentially effective treatment for seasonal eye allergies, a condition affecting millions of people worldwide.

4 May 2018

First Aid Article Series

A series of articles on First Aid for all ages.

4 May 2018

Study reveals essential malaria parasite genes

Researchers have exploited a quirk in the genetic make-up of the deadly malaria parasite, Plasmodium falciparum, to create 38,000 mutant strains and then determine which of the organism's genes are essential to its growth and survival.

3 May 2018

Long-term exposure to traffic-related pollution increases risk of pediatric asthma

Twenty-five million Americans suffer from asthma, a chronic lung disease that has been on the rise since the 1980s. While physicians have long known that smog and pollution can bring on an asthma attack among children and adults suffering from asthma, researchers remained uncertain about what role long-term exposure to certain pollutants might play in the development of the disease in children.

2 May 2018

Clinical trial tests natural treatment to provide long-term solution for chronic eczema

Eczema is the most common skin disease worldwide. People suffering from it often deal with a lifetime of painful symptoms. A new clinical trial is testing a natural treatment that researchers hope will provide a long-term solution for those dealing with the dry, itchy and painful skin that comes with chronic eczema.

30 Apr 2018

Allergies News and Research

Latest Allergies News and Research

Penn investigators discover source of immune molecule involved in nasal polyps, asthma

Scientists identify new drug target to combat chikungunya virus

Ozone exposure at birth linked to increased risk of developing asthma in childhood

Clinical trial begins enrollment to test safety of experimental MERS treatments

Microglia may play key role in slowing progression of prion diseases, research suggests

Researchers explore different strategies to keep kids with asthma out of hospital

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

New test developed for accurate and safe diagnosis of peanut allergies

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Poison ivy and poison oak can cause mild to severe allergic reactions

Mutations in EBOV-Makona do not alter disease-causing ability in animal models, shows study

OU researchers receive $5.7 million NIH grant to accelerate antibiotic discovery

Seasonal allergy symptoms can be misunderstood for learning disabilities in young children

Phase 2 clinical study of universal influenza vaccine begins in the United States

New eye drop may be potentially effective in treating seasonal eye allergies

First Aid Article Series

Study reveals essential malaria parasite genes

Long-term exposure to traffic-related pollution increases risk of pediatric asthma

Clinical trial tests natural treatment to provide long-term solution for chronic eczema

Innovation in neuroscience drug discovery - eBook eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Allergies News and Research

Latest Allergies News and Research

Innovation in neuroscience drug discovery - eBook eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in